Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Compound Endoscopic Morphological Features for Identifying Non-Pedunculated Lesions ≥20 mm with Intramucosal Neoplasia.

Cancers

da Costa-Seixas JP, López-Cerón M, Arnau A, Rosiñol Ò, Cuatrecasas M, Herreros-de-Tejada A, Ferrández Á, Serra-Burriel M, Nogales Ó, de Castro L, López-Vicente J, Vega P, Álvarez-González MA, González-Santiago JM, Hernández-Conde M, Diez-Redondo P, Rivero-Sánchez L, Gimeno-García AZ, Burgos A, García-Alonso FJ, Bustamante-Balén M, Martínez-Bauer E, Peñas B, Rodríguez-Alcalde D, Pellisé M, Puig I.
PMID: 34771472
Cancers (Basel). 2021 Oct 22;13(21). doi: 10.3390/cancers13215302.

BACKGROUND: The major limitation of piecemeal endoscopic mucosal resection (EMR) is the inaccurate histological assessment of the resected specimen, especially in cases of submucosal invasion.OBJECTIVE: To classify non-pedunculated lesions ≥20 mm based on endoscopic morphological features, in order to...

Cite
da Costa-Seixas JP, López-Cerón M, Arnau A, et al. Compound Endoscopic Morphological Features for Identifying Non-Pedunculated Lesions ≥20 mm with Intramucosal Neoplasia. Cancers (Basel). 2021;13(21)doi: 10.3390/cancers13215302.
da Costa-Seixas, J. P., López-Cerón, M., Arnau, A., Rosiñol, �. �., Cuatrecasas, M., Herreros-de-Tejada, A., Ferrández, �. �., Serra-Burriel, M., Nogales, �. �., de Castro, L., López-Vicente, J., Vega, P., Álvarez-González, M. A., González-Santiago, J. M., Hernández-Conde, M., Diez-Redondo, P., Rivero-Sánchez, L., Gimeno-García, A. Z., Burgos, A., García-Alonso, F. J., Bustamante-Balén, M., Martínez-Bauer, E., Peñas, B., Rodríguez-Alcalde, D., Pellisé, M., & Puig, I. (2021). Compound Endoscopic Morphological Features for Identifying Non-Pedunculated Lesions ≥20 mm with Intramucosal Neoplasia. Cancers, 13(21), . https://doi.org/10.3390/cancers13215302
da Costa-Seixas, João Pedro, et al. "Compound Endoscopic Morphological Features for Identifying Non-Pedunculated Lesions ≥20 mm with Intramucosal Neoplasia." Cancers vol. 13,21 (2021). doi: https://doi.org/10.3390/cancers13215302
da Costa-Seixas JP, López-Cerón M, Arnau A, Rosiñol Ò, Cuatrecasas M, Herreros-de-Tejada A, Ferrández Á, Serra-Burriel M, Nogales Ó, de Castro L, López-Vicente J, Vega P, Álvarez-González MA, González-Santiago JM, Hernández-Conde M, Diez-Redondo P, Rivero-Sánchez L, Gimeno-García AZ, Burgos A, García-Alonso FJ, Bustamante-Balén M, Martínez-Bauer E, Peñas B, Rodríguez-Alcalde D, Pellisé M, Puig I. Compound Endoscopic Morphological Features for Identifying Non-Pedunculated Lesions ≥20 mm with Intramucosal Neoplasia. Cancers (Basel). 2021 Oct 22;13(21). doi: 10.3390/cancers13215302. PMID: 34771472; PMCID: PMC8582371.
Copy Download .nbib Format: NLM
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.

Lancet (London, England)

Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP.
PMID: 34863359
Lancet. 2022 Jan 01;399(10319):61-116. doi: 10.1016/S0140-6736(21)01701-3. Epub 2021 Dec 02.

No abstract available.

Cite
Karlsen TH, Sheron N, Zelber-Sagi S, et al. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2021;399(10319):61-116doi: 10.1016/S0140-6736(21)01701-3.
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., Cecchini, M., Dirac, M. A., Belloni, A., Serra-Burriel, M., Ponsioen, C. Y., Sheena, B., Lerouge, A., Devaux, M., Scott, N., Hellard, M., Verkade, H. J., Sturm, E., Marchesini, G., Yki-Järvinen, H., Byrne, C. D., Targher, G., Tur-Sinai, A., Barrett, D., Ninburg, M., Reic, T., Taylor, A., Rhodes, T., Treloar, C., Petersen, C., Schramm, C., Flisiak, R., Simonova, M. Y., Pares, A., Johnson, P., Cucchetti, A., Graupera, I., Lionis, C., Pose, E., Fabrellas, N., Ma, A. T., Mendive, J. M., Mazzaferro, V., Rutter, H., Cortez-Pinto, H., Kelly, D., Burton, R., Lazarus, J. V., Ginès, P., Buti, M., Newsome, P. N., Burra, P., & Manns, M. P. (2022). The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet (London, England), 399(10319), 61-116. https://doi.org/10.1016/S0140-6736(21)01701-3
Karlsen, Tom H, et al. "The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality." Lancet (London, England) vol. 399,10319 (2022): 61-116. doi: https://doi.org/10.1016/S0140-6736(21)01701-3
Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2022 Jan 01;399(10319):61-116. doi: 10.1016/S0140-6736(21)01701-3. Epub 2021 Dec 02. PMID: 34863359.
Copy Download .nbib Format: NLM
Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Graupera I, Thiele M, Serra-Burriel M, Caballeria L, Roulot D, Lai-Hung Wong G, Fabrellas N, Guha IN, Arslanow A, Expósito C, Hernández R, Aithal GP, Galle PR, Pera G, Wai-Sun Wong V, Lammert F, Ginès P, Castera L, Krag A.
PMID: 34971806
Clin Gastroenterol Hepatol. 2021 Dec 28; doi: 10.1016/j.cgh.2021.12.034. Epub 2021 Dec 28.

BACKGROUND & AIMS: Fibrosis-4 (FIB-4) and the NAFLD fibrosis score (NFS) are the two most popular non-invasive blood-based serum tests proposed for widespread fibrosis screening. We therefore aimed to describe the accuracy of FIB-4 and NFS to detect elevated...

Cite
Graupera I, Thiele M, Serra-Burriel M, et al. Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population. Clin Gastroenterol Hepatol. 2021;doi: 10.1016/j.cgh.2021.12.034.
Graupera, I., Thiele, M., Serra-Burriel, M., Caballeria, L., Roulot, D., Lai-Hung Wong, G., Fabrellas, N., Guha, I. N., Arslanow, A., Expósito, C., Hernández, R., Aithal, G. P., Galle, P. R., Pera, G., Wai-Sun Wong, V., Lammert, F., Ginès, P., Castera, L., Krag, A. (2021). Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2021.12.034
Graupera, Isabel, et al. "Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2021). doi: https://doi.org/10.1016/j.cgh.2021.12.034
Graupera I, Thiele M, Serra-Burriel M, Caballeria L, Roulot D, Lai-Hung Wong G, Fabrellas N, Guha IN, Arslanow A, Expósito C, Hernández R, Aithal GP, Galle PR, Pera G, Wai-Sun Wong V, Lammert F, Ginès P, Castera L, Krag A. Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population. Clin Gastroenterol Hepatol. 2021 Dec 28; doi: 10.1016/j.cgh.2021.12.034. Epub 2021 Dec 28. PMID: 34971806.
Copy Download .nbib Format: NLM
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.

Hepatology (Baltimore, Md.)

Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A.
PMID: 34537988
Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10.

Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non-alcoholic fatty liver disease and alcohol-related liver disease, although chronic hepatitis B and C infections are still major etiological...

Cite
Ginès P, Castera L, Lammert F, et al. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2021;75(1):219-228doi: 10.1002/hep.32163.
Ginès, P., Castera, L., Lammert, F., Graupera, I., Serra-Burriel, M., Allen, A. M., Wong, V. W., Hartmann, P., Thiele, M., Caballeria, L., de Knegt, R. J., Grgurevic, I., Augustin, S., Tsochatzis, E. A., Schattenberg, J. M., Guha, I. N., Martini, A., Morillas, R. M., Garcia-Retortillo, M., de Koning, H. J., Fabrellas, N., Pich, J., Ma, A. T., Diaz, M. A., Roulot, D., Newsome, P. N., Manns, M., Kamath, P. S., Krag, A. (2022). Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology (Baltimore, Md.), 75(1), 219-228. https://doi.org/10.1002/hep.32163
Ginès, Pere, et al. "Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases." Hepatology (Baltimore, Md.) vol. 75,1 (2022): 219-228. doi: https://doi.org/10.1002/hep.32163
Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10. PMID: 34537988.
Copy Download .nbib Format: NLM
Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Sánchez A, Roos VH, Navarro M, Pineda M, Caballol B, Moreno L, Carballal S, Rodríguez-Alonso L, Ramon Y Cajal T, Llort G, Piñol V, López-Fernández A, Salces I, Picó MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E, López-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-Urrutia C, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E, Aguirre E, Romero C, Bastiaansen B, Gonzalez-Acosta M, Morales-Romero B, Ocaña T, Rivero-Sánchez L, Jung G, Bessa X, Cubiella J, Jover R, Rodríguez-Moranta F, Balmaña J, Brunet J, Castells A, Dekker E, Capella G, Serra-Burriel M, Moreira L, Pellise M, Balaguer F.
PMID: 33157315
Clin Gastroenterol Hepatol. 2020 Nov 03; doi: 10.1016/j.cgh.2020.11.002. Epub 2020 Nov 03.

BACKGROUND & AIMS: Colonoscopy reduces colorectal cancer (CRC) incidence and mortality in Lynch syndrome (LS) carriers. However, a high incidence of postcolonoscopy CRC (PCCRC) has been reported. Colonoscopy is highly dependent on endoscopist skill and is subject to quality...

Cite
Sánchez A, Roos VH, Navarro M, et al. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clin Gastroenterol Hepatol. 2020;doi: 10.1016/j.cgh.2020.11.002.
Sánchez, A., Roos, V. H., Navarro, M., Pineda, M., Caballol, B., Moreno, L., Carballal, S., Rodríguez-Alonso, L., Ramon Y Cajal, T., Llort, G., Piñol, V., López-Fernández, A., Salces, I., Picó, M. D., Rivas, L., Bujanda, L., Garzon, M., Pizarro, A., Martinez de Castro, E., López-Arias, M. J., Poves, C., Garau, C., Rodriguez-Alcalde, D., Herraiz, M., Alvarez-Urrutia, C., Dacal, A., Carrillo-Palau, M., Cid, L., Ponce, M., Barreiro-Alonso, E., Saperas, E., Aguirre, E., Romero, C., Bastiaansen, B., Gonzalez-Acosta, M., Morales-Romero, B., Ocaña, T., Rivero-Sánchez, L., Jung, G., Bessa, X., Cubiella, J., Jover, R., Rodríguez-Moranta, F., Balmaña, J., Brunet, J., Castells, A., Dekker, E., Capella, G., Serra-Burriel, M., Moreira, L., Pellise, M., & Balaguer, F. (2020). Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2020.11.002
Sánchez, Ariadna, et al. "Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2020). doi: https://doi.org/10.1016/j.cgh.2020.11.002
Sánchez A, Roos VH, Navarro M, Pineda M, Caballol B, Moreno L, Carballal S, Rodríguez-Alonso L, Ramon Y Cajal T, Llort G, Piñol V, López-Fernández A, Salces I, Picó MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E, López-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-Urrutia C, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E, Aguirre E, Romero C, Bastiaansen B, Gonzalez-Acosta M, Morales-Romero B, Ocaña T, Rivero-Sánchez L, Jung G, Bessa X, Cubiella J, Jover R, Rodríguez-Moranta F, Balmaña J, Brunet J, Castells A, Dekker E, Capella G, Serra-Burriel M, Moreira L, Pellise M, Balaguer F. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clin Gastroenterol Hepatol. 2020 Nov 03; doi: 10.1016/j.cgh.2020.11.002. Epub 2020 Nov 03. PMID: 33157315.
Copy Download .nbib Format: NLM
Machine Learning-Based Clustering Analysis: Foundational Concepts, Methods, and Applications.

Acta neurochirurgica. Supplement

Serra-Burriel M, Ames C.
PMID: 34862532
Acta Neurochir Suppl. 2022;134:91-100. doi: 10.1007/978-3-030-85292-4_12.

Unsupervised learning, the task of clustering observations in such a way that observations within cluster are more similar than those assigned to other clusters is one the central tasks of data science. Its exploratory and descriptive nature make it...

Cite
Serra-Burriel M, Ames C. Machine Learning-Based Clustering Analysis: Foundational Concepts, Methods, and Applications. Acta Neurochir Suppl. 2022;134:91-100doi: 10.1007/978-3-030-85292-4_12.
Serra-Burriel, M., & Ames, C. (2022). Machine Learning-Based Clustering Analysis: Foundational Concepts, Methods, and Applications. Acta neurochirurgica. Supplement, 13491-100. https://doi.org/10.1007/978-3-030-85292-4_12
Serra-Burriel, Miquel, and Ames, Christopher. "Machine Learning-Based Clustering Analysis: Foundational Concepts, Methods, and Applications." Acta neurochirurgica. Supplement vol. 134 (2022): 91-100. doi: https://doi.org/10.1007/978-3-030-85292-4_12
Serra-Burriel M, Ames C. Machine Learning-Based Clustering Analysis: Foundational Concepts, Methods, and Applications. Acta Neurochir Suppl. 2022;134:91-100. doi: 10.1007/978-3-030-85292-4_12. PMID: 34862532.
Copy Download .nbib Format: NLM
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.

Lancet (London, England)

Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP.
PMID: 34863359
Lancet. 2021 Dec 01; doi: 10.1016/S0140-6736(21)01701-3. Epub 2021 Dec 01.

No abstract available.

Cite
Karlsen TH, Sheron N, Zelber-Sagi S, et al. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2021;doi: 10.1016/S0140-6736(21)01701-3.
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., Cecchini, M., Dirac, M. A., Belloni, A., Serra-Burriel, M., Ponsioen, C. Y., Sheena, B., Lerouge, A., Devaux, M., Scott, N., Hellard, M., Verkade, H. J., Sturm, E., Marchesini, G., Yki-Järvinen, H., Byrne, C. D., Targher, G., Tur-Sinai, A., Barrett, D., Ninburg, M., Reic, T., Taylor, A., Rhodes, T., Treloar, C., Petersen, C., Schramm, C., Flisiak, R., Simonova, M. Y., Pares, A., Johnson, P., Cucchetti, A., Graupera, I., Lionis, C., Pose, E., Fabrellas, N., Ma, A. T., Mendive, J. M., Mazzaferro, V., Rutter, H., Cortez-Pinto, H., Kelly, D., Burton, R., Lazarus, J. V., Ginès, P., Buti, M., Newsome, P. N., Burra, P., & Manns, M. P. (2021). The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet (London, England), . https://doi.org/10.1016/S0140-6736(21)01701-3
Karlsen, Tom H, et al. "The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality." Lancet (London, England) vol. (2021). doi: https://doi.org/10.1016/S0140-6736(21)01701-3
Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2021 Dec 01; doi: 10.1016/S0140-6736(21)01701-3. Epub 2021 Dec 01. PMID: 34863359.
Copy Download .nbib Format: NLM
Development and validation of risk stratification models for adult spinal deformity surgery.

Journal of neurosurgery. Spine

Pellisé F, Serra-Burriel M, Smith JS, Haddad S, Kelly MP, Vila-Casademunt A, Sánchez Pérez-Grueso FJ, Bess S, Gum JL, Burton DC, Acaroğlu E, Kleinstück F, Lafage V, Obeid I, Schwab F, Shaffrey CI, Alanay A, Ames C.
PMID: 31252385
J Neurosurg Spine. 2019 Jun 28;1-13. doi: 10.3171/2019.3.SPINE181452. Epub 2019 Jun 28.

OBJECTIVE: Adult spinal deformity (ASD) surgery has a high rate of major complications (MCs). Public information about adverse outcomes is currently limited to registry average estimates. The object of this study was to assess the incidence of adverse events...

Cite
Pellisé F, Serra-Burriel M, Smith JS, et al. Development and validation of risk stratification models for adult spinal deformity surgery. J Neurosurg Spine. 2019;1-13doi: 10.3171/2019.3.SPINE181452.
Pellisé, F., Serra-Burriel, M., Smith, J. S., Haddad, S., Kelly, M. P., Vila-Casademunt, A., Sánchez Pérez-Grueso, F. J., Bess, S., Gum, J. L., Burton, D. C., Acaroğlu, E., Kleinstück, F., Lafage, V., Obeid, I., Schwab, F., Shaffrey, C. I., Alanay, A., Ames, C. (2019). Development and validation of risk stratification models for adult spinal deformity surgery. Journal of neurosurgery. Spine, 1-13. https://doi.org/10.3171/2019.3.SPINE181452
Pellisé, Ferran, et al. "Development and validation of risk stratification models for adult spinal deformity surgery." Journal of neurosurgery. Spine vol. (2019): 1-13. doi: https://doi.org/10.3171/2019.3.SPINE181452
Pellisé F, Serra-Burriel M, Smith JS, Haddad S, Kelly MP, Vila-Casademunt A, Sánchez Pérez-Grueso FJ, Bess S, Gum JL, Burton DC, Acaroğlu E, Kleinstück F, Lafage V, Obeid I, Schwab F, Shaffrey CI, Alanay A, Ames C. Development and validation of risk stratification models for adult spinal deformity surgery. J Neurosurg Spine. 2019 Jun 28;1-13. doi: 10.3171/2019.3.SPINE181452. Epub 2019 Jun 28. PMID: 31252385.
Copy Download .nbib Format: NLM
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.

Hepatology (Baltimore, Md.)

Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A.
PMID: 34537988
Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10.

Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non-alcoholic fatty liver disease and alcohol-related liver disease, although chronic hepatitis B and C infections are still major etiological...

Cite
Ginès P, Castera L, Lammert F, et al. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2021;75(1):219-228doi: 10.1002/hep.32163.
Ginès, P., Castera, L., Lammert, F., Graupera, I., Serra-Burriel, M., Allen, A. M., Wong, V. W., Hartmann, P., Thiele, M., Caballeria, L., de Knegt, R. J., Grgurevic, I., Augustin, S., Tsochatzis, E. A., Schattenberg, J. M., Guha, I. N., Martini, A., Morillas, R. M., Garcia-Retortillo, M., de Koning, H. J., Fabrellas, N., Pich, J., Ma, A. T., Diaz, M. A., Roulot, D., Newsome, P. N., Manns, M., Kamath, P. S., Krag, A. (2022). Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology (Baltimore, Md.), 75(1), 219-228. https://doi.org/10.1002/hep.32163
Ginès, Pere, et al. "Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases." Hepatology (Baltimore, Md.) vol. 75,1 (2022): 219-228. doi: https://doi.org/10.1002/hep.32163
Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10. PMID: 34537988.
Copy Download .nbib Format: NLM
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.

Hepatology (Baltimore, Md.)

Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A.
PMID: 34537988
Hepatology. 2021 Sep 19; doi: 10.1002/hep.32163. Epub 2021 Sep 19.

Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non-alcoholic fatty liver disease and alcohol-related liver disease, although chronic hepatitis B and C infections are still major etiological...

Cite
Ginès P, Castera L, Lammert F, et al. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2021;doi: 10.1002/hep.32163.
Ginès, P., Castera, L., Lammert, F., Graupera, I., Serra-Burriel, M., Allen, A. M., Wong, V. W., Hartmann, P., Thiele, M., Caballeria, L., de Knegt, R. J., Grgurevic, I., Augustin, S., Tsochatzis, E. A., Schattenberg, J. M., Guha, I. N., Martini, A., Morillas, R. M., Garcia-Retortillo, M., de Koning, H. J., Fabrellas, N., Pich, J., Ma, A. T., Diaz, M. A., Roulot, D., Newsome, P. N., Manns, M., Kamath, P. S., Krag, A. (2021). Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology (Baltimore, Md.), . https://doi.org/10.1002/hep.32163
Ginès, Pere, et al. "Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases." Hepatology (Baltimore, Md.) vol. (2021). doi: https://doi.org/10.1002/hep.32163
Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2021 Sep 19; doi: 10.1002/hep.32163. Epub 2021 Sep 19. PMID: 34537988.
Copy Download .nbib Format: NLM
Improving the detection of infectious diseases in at-risk migrants with an innovative integrated multi-infection screening digital decision support tool (IS-MiHealth) in primary care: A pilot cluster-randomized controlled trial.

Journal of travel medicine

Sequeira-Aymar E, Cruz A, Serra-Burriel M, di Lollo X, Gonçalves AQ, Camps-Vilà L, Monclus-Gonzalez MM, Revuelta-Muñoz EM, Busquet-Solé N, Sarriegui-Domínguez S, Casellas A, Llorca MRD, Aguilar-Martín C, Jacques-Aviñó C, Hargreaves S, Requena-Méndez A.
PMID: 34230959
J Travel Med. 2021 Jul 06; doi: 10.1093/jtm/taab100. Epub 2021 Jul 06.

BACKGROUND: There are major shortfalls in the identification and screening of at-risk migrant groups. This study aims to evaluate the effectiveness of a new digital tool (IS-MiHealth) integrated into the electronic patient record system of primary care centres in...

Cite
Sequeira-Aymar E, Cruz A, Serra-Burriel M, et al. Improving the detection of infectious diseases in at-risk migrants with an innovative integrated multi-infection screening digital decision support tool (IS-MiHealth) in primary care: A pilot cluster-randomized controlled trial. J Travel Med. 2021;doi: 10.1093/jtm/taab100.
Sequeira-Aymar, E., Cruz, A., Serra-Burriel, M., di Lollo, X., Gonçalves, A. Q., Camps-Vilà, L., Monclus-Gonzalez, M. M., Revuelta-Muñoz, E. M., Busquet-Solé, N., Sarriegui-Domínguez, S., Casellas, A., Llorca, M. R. D., Aguilar-Martín, C., Jacques-Aviñó, C., Hargreaves, S., & Requena-Méndez, A. (2021). Improving the detection of infectious diseases in at-risk migrants with an innovative integrated multi-infection screening digital decision support tool (IS-MiHealth) in primary care: A pilot cluster-randomized controlled trial. Journal of travel medicine, . https://doi.org/10.1093/jtm/taab100
Sequeira-Aymar, Ethel, et al. "Improving the detection of infectious diseases in at-risk migrants with an innovative integrated multi-infection screening digital decision support tool (IS-MiHealth) in primary care: A pilot cluster-randomized controlled trial." Journal of travel medicine vol. (2021). doi: https://doi.org/10.1093/jtm/taab100
Sequeira-Aymar E, Cruz A, Serra-Burriel M, di Lollo X, Gonçalves AQ, Camps-Vilà L, Monclus-Gonzalez MM, Revuelta-Muñoz EM, Busquet-Solé N, Sarriegui-Domínguez S, Casellas A, Llorca MRD, Aguilar-Martín C, Jacques-Aviñó C, Hargreaves S, Requena-Méndez A. Improving the detection of infectious diseases in at-risk migrants with an innovative integrated multi-infection screening digital decision support tool (IS-MiHealth) in primary care: A pilot cluster-randomized controlled trial. J Travel Med. 2021 Jul 06; doi: 10.1093/jtm/taab100. Epub 2021 Jul 06. PMID: 34230959.
Copy Download .nbib Format: NLM
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in .

Journal of clinical medicine

Dominguez-Valentin M, Plazzer JP, Sampson JR, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Macrae F, Winship IM, Thomas H, Evans DG, Burn J, Greenblatt M, de Vos Tot Nederveen Cappel WH, Sijmons RH, Nielsen M, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Lindblom A, Valle AD, Lopez-Kostner F, Alvarez K, Gluck N, Katz L, Heinimann K, Vaccaro CA, Nakken S, Hovig E, Green K, Lalloo F, Hill J, Vasen HFA, Perne C, Büttner R, Görgens H, Holinski-Feder E, Morak M, Holzapfel S, Hüneburg R, von Knebel Doeberitz M, Loeffler M, Rahner N, Weitz J, Steinke-Lange V, Schmiegel W, Vangala D, Crosbie EJ, Pineda M, Navarro M, Brunet J, Moreira L, Sánchez A, Serra-Burriel M, Mints M, Kariv R, Rosner G, Piñero TA, Pavicic WH, Kalfayan P, Broeke SWT, Mecklin JP, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Peltomäki P, Hopper JL, Win AK, Buchanan DD, Lindor NM, Gallinger S, Marchand LL, Newcomb PA, Figueiredo JC, Thibodeau SN, Therkildsen C, Hansen TVO, Lindberg L, Rødland EA, Neffa F, Esperon P, Tjandra D, Möslein G, Seppälä TT, Møller P.
PMID: 34203177
J Clin Med. 2021 Jun 28;10(13). doi: 10.3390/jcm10132856.

BACKGROUND: Lynch syndrome is the most common genetic predisposition for hereditary cancer. Carriers of pathogenic changes in mismatch repair (MMR) genes have an increased risk of developing colorectal (CRC), endometrial, ovarian, urinary tract, prostate, and other cancers, depending on...

Cite
Dominguez-Valentin M, Plazzer JP, Sampson JR, et al. No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in . J Clin Med. 2021;10(13)doi: 10.3390/jcm10132856.
Dominguez-Valentin, M., Plazzer, J. P., Sampson, J. R., Engel, C., Aretz, S., Jenkins, M. A., Sunde, L., Bernstein, I., Capella, G., Balaguer, F., Macrae, F., Winship, I. M., Thomas, H., Evans, D. G., Burn, J., Greenblatt, M., de Vos Tot Nederveen Cappel, W. H., Sijmons, R. H., Nielsen, M., Bertario, L., Bonanni, B., Tibiletti, M. G., Cavestro, G. M., Lindblom, A., Valle, A. D., Lopez-Kostner, F., Alvarez, K., Gluck, N., Katz, L., Heinimann, K., Vaccaro, C. A., Nakken, S., Hovig, E., Green, K., Lalloo, F., Hill, J., Vasen, H. F. A., Perne, C., Büttner, R., Görgens, H., Holinski-Feder, E., Morak, M., Holzapfel, S., Hüneburg, R., von Knebel Doeberitz, M., Loeffler, M., Rahner, N., Weitz, J., Steinke-Lange, V., Schmiegel, W., Vangala, D., Crosbie, E. J., Pineda, M., Navarro, M., Brunet, J., Moreira, L., Sánchez, A., Serra-Burriel, M., Mints, M., Kariv, R., Rosner, G., Piñero, T. A., Pavicic, W. H., Kalfayan, P., Broeke, S. W. T., Mecklin, J. P., Pylvänäinen, K., Renkonen-Sinisalo, L., Lepistö, A., Peltomäki, P., Hopper, J. L., Win, A. K., Buchanan, D. D., Lindor, N. M., Gallinger, S., Marchand, L. L., Newcomb, P. A., Figueiredo, J. C., Thibodeau, S. N., Therkildsen, C., Hansen, T. V. O., Lindberg, L., Rødland, E. A., Neffa, F., Esperon, P., Tjandra, D., Möslein, G., Seppälä, T. T., & Møller, P. (2021). No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in . Journal of clinical medicine, 10(13), . https://doi.org/10.3390/jcm10132856
Dominguez-Valentin, Mev, et al. "No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in ." Journal of clinical medicine vol. 10,13 (2021). doi: https://doi.org/10.3390/jcm10132856
Dominguez-Valentin M, Plazzer JP, Sampson JR, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Macrae F, Winship IM, Thomas H, Evans DG, Burn J, Greenblatt M, de Vos Tot Nederveen Cappel WH, Sijmons RH, Nielsen M, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Lindblom A, Valle AD, Lopez-Kostner F, Alvarez K, Gluck N, Katz L, Heinimann K, Vaccaro CA, Nakken S, Hovig E, Green K, Lalloo F, Hill J, Vasen HFA, Perne C, Büttner R, Görgens H, Holinski-Feder E, Morak M, Holzapfel S, Hüneburg R, von Knebel Doeberitz M, Loeffler M, Rahner N, Weitz J, Steinke-Lange V, Schmiegel W, Vangala D, Crosbie EJ, Pineda M, Navarro M, Brunet J, Moreira L, Sánchez A, Serra-Burriel M, Mints M, Kariv R, Rosner G, Piñero TA, Pavicic WH, Kalfayan P, Broeke SWT, Mecklin JP, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Peltomäki P, Hopper JL, Win AK, Buchanan DD, Lindor NM, Gallinger S, Marchand LL, Newcomb PA, Figueiredo JC, Thibodeau SN, Therkildsen C, Hansen TVO, Lindberg L, Rødland EA, Neffa F, Esperon P, Tjandra D, Möslein G, Seppälä TT, Møller P. No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in . J Clin Med. 2021 Jun 28;10(13). doi: 10.3390/jcm10132856. PMID: 34203177; PMCID: PMC8269121.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries